Cargando…
The Development of an AIDS Mucosal Vaccine
It is well known that mucosal tissues contain the largest surface area of the human body and are the front line of natural host defense against various pathogens. In fact, more than 80% of infectious disease pathogens probably gain entry into the susceptible human hosts through open mucosal surfaces...
Autores principales: | Tang, Xian, Chen, Zhiwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185548/ https://www.ncbi.nlm.nih.gov/pubmed/21994611 http://dx.doi.org/10.3390/v2010283 |
Ejemplares similares
-
CS14-04 The Development of an AIDS Mucosal Vaccine
por: Chen, Zhiwei
Publicado: (2009) -
Use of Nonhuman Primate Models to Develop Mucosal AIDS Vaccines
por: Genescà, Meritxell, et al.
Publicado: (2010) -
Development of mucosal vaccine delivery: an overview on the mucosal vaccines and their adjuvants
por: Anggraeni, Rahmi, et al.
Publicado: (2022) -
Myeloid Cell-Mediated Trained Innate Immunity in Mucosal AIDS Vaccine Development
por: Sui, Yongjun, et al.
Publicado: (2020) -
Mucosal Vaccine Development Based on Liposome Technology
por: Bernasconi, Valentina, et al.
Publicado: (2016)